ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      19,172.00
      1.67%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      73.915
      2.12%
      Bitcoin
      61,978.66
      0.50%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Adaptive Biotechnologies Corporation (ADPT) Quote

      Adaptive Biotechnologies Corporation

      Adaptive Biotechnologies Corporation (ADPT)

      Adaptogenics Health Corp
      4.61
      -0.02
      (-0.43%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      4.61
      0.00
      ( 0.00% )
      Pre Market: 4:11AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      4.61
      Bid
      4.40
      Ask
      4.90
      Volume
      -
      0.00 Day's Range 0.00
      2.28 52 Week Range 6.34
      Market Cap
      679.847M
      Previous Close
      4.61
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,261,171
      Shares Outstanding
      147,472,201
      Dividend Yield
      -
      PE Ratio
      -3.02
      Earnings Per Share (EPS)
      -1.53
      Revenue
      170.28M
      Net Profit
      -225.25M

      About Adaptive Biotechnologies Corporation

      Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.adaptivebiotech.com
      Headquarters
      Olympia, Washington, USA
      Founded
      -
      Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $4.61. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 6.34.

      Adaptive Biotechnologies currently has 147,472,201 shares outstanding. The market capitalization of Adaptive Biotechnologies is $679.85 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -3.02.

      Ask ADVFN Intelligence (AI)

      ADPT Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      18 hours ago

      Adaptive Announces IVDR Certification for clonoSEQ® in European Union

      SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

      August 29 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      August 23 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      August 22 2024
      Edgar (US Regulatory)

      Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

      SEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

      August 22 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 01 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 01 2024
      Edgar (US Regulatory)

      Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

      SEATTLE, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...

      August 01 2024
      GlobeNewswire Inc.

      Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

      SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

      July 11 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 11 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.214.772727272734.44.984.248009824.55738333CS
      4-0.01-0.216450216454.624.984.0857723204.51121648CS
      121.2838.43843843843.335.043.2612611714.263275CS
      261.4746.81528662423.145.042.2814795043.55965442CS
      52-0.895-16.25794732065.5056.342.2815000233.97068144CS
      156-33.94-88.041504539638.5539.622.2812471918.27923426CS
      260-35.13-88.39959738339.7471.252.28111034918.54620082CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ZEOZeo Energy Corporation
      $ 4.28
      (275.44%)
      		1.13M
      XCURExicure Inc
      $ 6.87
      (200.00%)
      		1.68M
      TBIOTelesis Bio Inc
      $ 3.00
      (120.59%)
      		1.26M
      VEROVenus Concept Inc
      $ 0.9029
      (79.68%)
      		1.85M
      FRGTFreight Technologies Inc
      $ 0.1819
      (46.81%)
      		8.22M
      PGNYProgyny Inc
      $ 18.40
      (-24.71%)
      		19.81k
      VEEAVeea Inc
      $ 9.60
      (-21.63%)
      		22.18k
      OMOutset Medical Inc
      $ 0.5238
      (-19.42%)
      		1.02k
      WBUYWeBuy Global Ltd
      $ 0.1523
      (-17.36%)
      		304.68k
      CLEUChina Liberal Education Holdings Ltd
      $ 0.2301
      (-13.10%)
      		67
      FRGTFreight Technologies Inc
      $ 0.1819
      (46.81%)
      		8.22M
      VEROVenus Concept Inc
      $ 0.9029
      (79.68%)
      		1.85M
      XCURExicure Inc
      $ 6.87
      (200.00%)
      		1.68M
      EJHE Home Household Service Holdings Ltd
      $ 0.1132
      (6.79%)
      		1.64M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.1052
      (15.73%)
      		1.33M

      Discussion

      View Full Feed
      tw0122 tw0122 1 minute ago
      Cashing out at $27.90 thank you Powell and Yellen PPT team
      SVIX
      tw0122 tw0122 2 minutes ago
      Cashing out at $69 thank you Powell and Yellen PPT team
      TQQQ
      Ms Labonte Ms Labonte 2 minutes ago
      Wakey wakey junkie$$ the future looks very bright today$$$
      RNAZ
      sectorspider sectorspider 5 minutes ago
      FINRA denied HMBL
      Nice allowance but ticker is decimated
      HMBL
      EnigmaticKraken98 EnigmaticKraken98 8 minutes ago
      AZ Teams Up with Level 10 for U.S. Rollout of Smart Carts

      On September 19, 2024, A2Z Cust2mate Solutions Corp. ("A2Z"), a tech company known for its innovative solutions, announced a partnership with Level 10, LLC, a top retail IT service provider. The agreement focuses on installin
      INTL
      tw0122 tw0122 8 minutes ago
      Since the summer of 2018, there has been zero job creation for native-born workers...

      Why have all new jobs since 2018 gone to foreign-born workers (i.e. immigrants)? Because you can be an illegal immigrant in deportation proceedings (not to mention anyone seeking asylum) and get aut
      NVDA
      falkus951 falkus951 11 minutes ago
      $LUXH 1:00 AM PST VOLUME TRADING UP% pre market

      CEO with STRONG hotel management exp bought shares of stock last month. + NO R/S. He knows something
      1. Insider Purchase http://openinsider.com/search?q=luxh
      2. https://stockcharts.com/sc3/ui/?s=LUXH&id=p07205851717
      LUXH
      falkus951 falkus951 12 minutes ago
      $LUXH 1:00 AM PST VOLUME TRADING UP% pre market

      CEO with STRONG hotel management exp bought shares of stock last month. + NO R/S. He knows something
      1. Insider Purchase http://openinsider.com/search?q=luxh
      2. https://stockcharts.com/sc3/ui/?s=LUXH&id=p07205851717
      LUXH
      RickNagra RickNagra 13 minutes ago
      Oh wow. I sm exactly expecting a massive super duper big win from the team and the players. No doubt Ron is a real person or even a politician or a genius. He knows everything. A literal legend and a great leader. Everyone should raise their glass to the world Ron. Please allow me to share my
      GNCP
      Ms Labonte Ms Labonte 13 minutes ago
      Going to the next level penny flipper$$$ .50 coming today… buy you all out ….
      RNAZ
      falkus951 falkus951 13 minutes ago
      $LUXH 1:00 AM PST VOLUME TRADING UP% pre market

      CEO with STRONG hotel management exp bought shares of stock last month. + NO R/S. He knows something
      1. Insider Purchase http://openinsider.com/search?q=luxh
      2. https://stockcharts.com/sc3/ui/?s=LUXH&id=p07205851717
      LUXH
      Ms Labonte Ms Labonte 14 minutes ago
      My pimp$ got their eye$ on you flipper$$$$
      RNAZ
      tw0122 tw0122 16 minutes ago
      $28 keep on pumping PPT $30 closer
      SVIX
      tw0122 tw0122 17 minutes ago
      Told you $70 coming PPT team pumping markets hard early on
      TQQQ
      tw0122 tw0122 20 minutes ago
      TBIO 3.80 + 180% push it more honest hedge funds we luv it
      TBIO
      tw0122 tw0122 21 minutes ago
      Missing out on ZEO TBIO and FRGT wake up lol
      FRGT TBIO ZEO
      tw0122 tw0122 22 minutes ago
      Pump it more $3.20 + 120% now. I luv Gary Gensler
      TBIO
      jrsh jrsh 23 minutes ago
      Yep, unbelievable, they just don't get it that announcements without following through are undermining trust and confidence big time and it would be much better to hold back until being sure!!!

      They still owe us several game changers, great news ahead and other information!!!
      NSAV
      Ms Labonte Ms Labonte 23 minutes ago
      .50 on radar $creen today… lookout for leg$$ $trait up$$$$
      CREEN TRAIT
      dennisdave dennisdave 25 minutes ago
      Yes
      And at ASM they said they haven’t even started the process of writing the pricing model to submit for appraisal as far as I remember and no timeline was given ( unless you consider several months as a timeline )

      I know that is one reason we have tanked 32% since then. But t
      ASM NWBO
      snow snow 28 minutes ago
      I listened to part of the interview. I was not impressed by the performance of management. What is positive is that the company will try to expand the sms business that has better profit margins than the voice business. If I did not misunderstand the hope is to improve the bottom line by two million
      IQST
      toohot toohot 28 minutes ago
      Everything at BIEL is progressing. Don’t let the egg sucking dogs detour your beliefs!





      BUY $BIEL$
      BIEL
      tw0122 tw0122 29 minutes ago
      Zeo $6 + 400% let’s go
      ZEO

      Your Recent History

      NASDAQ
      ADPT
      Adaptive Biotechnologies
      Delayed Upgrade Clock